Treatment of chronic granulocytic leukemia in blastic crisis.
Canellos
G P
GP
Dana-Farber Cancer Institute, Boston, Massachusetts.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001752:Blast Crisis / Q000188:drug therapy*; D001803:Blood Transfusion; D016026:Bone Marrow Transplantation; D003131:Combined Modality Therapy; D003561:Cytarabine / Q000008:administration & dosage / Q000627:therapeutic use; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007370:Interferon Type I / Q000627:therapeutic use; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy / Q000473:pathology* / Q000601:surgery; D013156:Splenectomy
D007370:Interferon Type I; D003561:Cytarabine